Pair Name | Sulforaphane, PP242 | ||
Phytochemical Name | Sulforaphane (PubChem CID: 5350 ) | ||
Anticancer drug Name | PP242 (PubChem CID: 135565635 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Sulforaphane, PP242 | |||
Disease Info | [ICD-11: 2B70] | Esophageal cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Down-regulation | Phosphorylation | AKT1S1 | hsa84335 | |
Up-regulation | Expression | BAX | hsa581 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Down-regulation | Phosphorylation | RICTOR | hsa253260 | |
Down-regulation | Phosphorylation | RPS6KB1 | hsa6198 | |
In Vitro Model | Eca-109 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_6898 |
EC9706 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_E307 | |
Result | Our findings demonstrate that PP242 enhances the anti-tumor activity of SFN by blocking SFN-induced activation of Akt/mTOR pathway in ESCC, which provides a rationale for treating ESCC using SFN combined with Akt/mTOR pathway inhibitors. |
No. | Title | Href |
---|---|---|
1 | mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma. Mol Biol Rep. 2022 Jan;49(1):451-461. doi: 10.1007/s11033-021-06895-9. | Click |